Drawing for BIONOV

USPTO serial 88373603

BIONOV

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
FLOWERS, JAY K
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIONOV?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III TEPPER & EYSTER, PLLC3724 BENSON DRIVERALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Apparatus and equipment for processing data and information, namely, apparatus for recording, transmission, processing and reproduction of sound, images or data; Apparatus and equipment for processing data and information, namely, computer hardware and recorded computer software, for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; downloadable computer programs for providing information on health and wellness, for entering new medical patient data into a database containing pre-recorded medical patient data, for managing and analyzing medical patient data within the database, for users to track their symptoms and record their treatments, for users to track physical activity and vital signs, for accessing and aggregating immunization data for use by health care providers, for tracking, recording and sharing healthcare information; downloadable computer software for analyzing, storing and monitoring of physiological data, including diagnostic, monitoring and warning tools; Personal digital assistants; downloadable data analysis software for use by health care providers to customize treatments based on patient profiles; Downloadable mobile software application for medical professionals and patients featuring information and related diagnostic data input from remote locations via electronic patient monitoring devices that feed information to the mobile application for use by medical professionals for purposes of monitoring and diagnosing medical conditions; downloadable artificial intelligence software for healthcare in the field of medical diagnostics; downloadable artificial intelligence software for analysis in the field of cancerACTIVE—
010Medical analysis instruments for detecting and treating cancer ; Medical diagnostic instruments for detecting cancer ; Medical device for detecting cancer; Medical device for treating cancer ; Computer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus during the process of diagnosis of a condition in an individualACTIVE—
035Collection, compilation and storage of data into computer databases; Updating, processing and maintenance of data in computer databases; Business advice and consultancy relating to financing business data analytics; Systemization of information into computer databases; Compilation of statistics; Business research and data analysis services in the field of genomics, medicine and life sciences; Business research and data analysis services in the field of cancer research, diagnostics, disease classification and personalized medicine; Providing an on-line database providing business intelligence in the fields of medical devices, pharmaceuticals, and life sciences; all the aforesaid being provided in relation with the medical and pharmaceutical fieldACTIVE—
042Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reportsACTIVE—
044Medical services; Providing medical testing services for diagnostic or treatment purposes and information in the field of personalized medicine; Advisory services relating to health; Pharmaceutical advice; Telemedicine services; Medical diagnostic testing, monitoring and reporting services; Medical reporting services, namely, compilation of medical reports; consultancy and information services relating to medical and pharmaceutical products; health consultancy and health counseling; health screening services in the fields of human physiology, activity, sleep, sleep apnea, cardiovascular health, dermatology, hearing, neurology, cancer, endocrinology, hormone and metabolic health; Medical diagnosis and treatment of cancer; medical evaluation of cancer, molecular tumor profiles, biological data and genetic information for the purposes of determining the most promising personalized treatment options ; Medical assistance services provided via telecommunication and global computer networks for individuals with health problems through the use of wearable medical devices with automated alert and monitoring capacity; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; Medical diagnostic testing, monitoring and reporting serviceACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 7, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 7, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 22, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 21, 2022EX5GSOU EXTENSION 5 GRANTED—
Mar 30, 2022EXT5SOU EXTENSION 5 FILED—
Mar 30, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 2, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 30, 2021EX4GSOU EXTENSION 4 GRANTED—
Sep 30, 2021EXT4SOU EXTENSION 4 FILED—
Sep 30, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 1, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 30, 2021EX3GSOU EXTENSION 3 GRANTED—
Mar 30, 2021EXT3SOU EXTENSION 3 FILED—
Mar 30, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 1, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 29, 2020EX2GSOU EXTENSION 2 GRANTED—
Sep 29, 2020EXT2SOU EXTENSION 2 FILED—
Sep 29, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 28, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 26, 2020EX1GSOU EXTENSION 1 GRANTED—
Mar 26, 2020EXT1SOU EXTENSION 1 FILED—
Mar 26, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 18, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 18, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 10, 2019EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Oct 1, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 6, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 6, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 17, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 28, 2019ALIEASSIGNED TO LIE—
Jun 18, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 7, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 7, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 7, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 1, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 31, 2019DOCKASSIGNED TO EXAMINER—
Apr 23, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 9, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance